Navigation Links
Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452
Date:5/26/2009

er information regarding these and other risks related to Cytokinetics' business, investors should consult Cytokinetics' filings with the Securities and Exchange Commission.

    CONTACT: Cytokinetics, South San Francisco
    Chris Keenan, Director Investor Relations & Media
    650-624-3026 or 415-505-2581 (mobile)

    CONTACT: Amgen, Thousand Oaks
    Mary Klem, 805-447-6979 or 805-341-0687 (mobile) (Media)
    Arvind Sood, 805-447-1060 (Investors)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20090526/CYTOLOGO)


'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Amgen Announces Voting Results Of Annual Meeting Of Stockholders
2. Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
3. Preclinical Data From Amgens Oncology Pipeline to be Presented at AACR
4. Amgen to Present at the Cowen and Company Annual Healthcare Conference
5. FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
6. Amgens Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
7. Amgens Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
8. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
9. Amgen to Present at the 27th Annual JP Morgan Healthcare Conference
10. Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe
11. Amgen Positioned to Deliver Attractive Growth Over Next Five Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 15 , ... Evaluate the Ability of,Cardiopoietic Cells to Restore Cardiac ... a leading Belgian biotechnology company specialising,in cell-based therapies ... it has completed, two months ahead of schedule,enrolment ... II/III trial of C-Cure, a,unique stem cell therapy ...
(Date:12/14/2009)... Dec. 14 Vermillion, Inc. (Pink ... announced William C. Wallen, Ph.D. Chief Scientific ... for IDEXX Laboratories, will be joining its ... bankruptcy plan. ,, "Bill brings more ... in diagnostics and biotechnology," said Gail Page, ...
(Date:12/14/2009)... ROCKAWAY, N.J., Dec. 14 The third ... Approach , published by the ... FDA-approved treatment for anthracycline extravasation.(1) Anthracyclines are ... idarubicin and epirubicin that have been used in ... the early 1970s.(2) ,, According to ...
(Date:12/14/2009)... SAN CARLOS, Calif., Dec. 14 Nektar ... Dennis Winger has been appointed to serve on ... highly-respected biopharmaceutical industry leader with over 35 years ... strategy. ,, "Dennis brings to Nektar extensive industry ... evolution," said Howard W. Robin, President and CEO ...
Breaking Biology Technology:Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3
... to ... 66.3% - Company Prepares to Launch Newest Generation of Laser Lipolysis ... Technology, WESTFORD, Mass., ... array of,light-based aesthetic treatment systems, today announced record revenues,and gross margin for the quarter ended March ...
... released a collection of important papers addressing a ... and social implications. The anthology Nanotechnology and ... contentious issues as environmental impact, health dangers, medical ... international governance, and more. , The anthology features ...
... Dacogen Royalty Revenue Increases 114% from Same Prior Year ... SUPG ) today reported financial results for the ... the 2008 first quarter were $8.1 million, compared,with $4.4 ... for the,2008 first quarter consisted of $8.1 million in ...
Other Biology Technology:Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 2Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 3Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 4Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 5Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 6Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 7Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 8Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 9Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 10Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 11Springer publishes anthology with the Nanoethics Group 2SuperGen Reports 2008 First Quarter Financial Results 2SuperGen Reports 2008 First Quarter Financial Results 3SuperGen Reports 2008 First Quarter Financial Results 4SuperGen Reports 2008 First Quarter Financial Results 5SuperGen Reports 2008 First Quarter Financial Results 6SuperGen Reports 2008 First Quarter Financial Results 7SuperGen Reports 2008 First Quarter Financial Results 8SuperGen Reports 2008 First Quarter Financial Results 9
(Date:12/15/2009)... as babies are born, they are susceptible to diseases ... to a month, their immune systems aren,t adequately developed ... they can lead to serious problems if left untreated. ... researchers have pinpointed a group of depleted white blood ... "We,re trying to improve the immune system of newborns ...
(Date:12/15/2009)... VIB and Ghent University in Flanders, Belgium have found ... the major cause of death in intensive care units. ... in mice with septic shock, researchers Anje Cauwels and ... less damage, while their chances of survival increased significantly. ... assumed that nitric oxide is responsible for the potentially ...
(Date:12/15/2009)... In the near future, consumers can look forward ... such as laptops, PDAs and mobile phones. This ... energy harvesting technologies which are critical elements for ... devices and systems. , Analog IC design is ... energy harvesting. To pre-position the nation in advanced ...
Breaking Biology News(10 mins):Researchers work on vaccine to improve immune system in newborns 2Septic shock: Nitric oxide beneficial after all 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3Bioheart Inc Announces Receipt of 242 8 Million in Proceeds From Pipe Financing 51264 1Bioheart Inc Announces Receipt of 242 8 Million in Proceeds From Pipe Financing 51264 2Bioheart Inc Announces Receipt of 242 8 Million in Proceeds From Pipe Financing 51264 3Blue Cross and Blue Shield of Illinois Awards 241 4 Million to 14 Community Initiatives in Chicago and Downstate 51262 1Blue Cross and Blue Shield of Illinois Awards 241 4 Million to 14 Community Initiatives in Chicago and Downstate 51262 2Oral body inflammatory connection explained 51261 1Oral body inflammatory connection explained 51261 2Oral body inflammatory connection explained 51261 3
... so-called Jekyll and Hyde bacteria, suggesting a novel way ... at the University of York studied the relationship between ... and discovered an unexpected interaction. , Plants are ... thrive on plant food only because of the presence ...
... For Immediate Release - A catalytic antibody discovery made ... of the upcoming acquisition of biotechnology venture CovX by ... that our scientific findings have found such a broad ... M.D., president of Scripps Research. "This development underlines the ...
... and vegetation allowed human ancestors to evolve in Africa. ... to the idea that ground movements formed mountains and ... , Tectonics [movement of Earths crust] was ultimately responsible ... of the universitys Energy and Geoscience Institute write in ...
Other Biology News:Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal 2Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal 3Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal 4Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal 5Evolution tied to Earth movement 2Evolution tied to Earth movement 3Evolution tied to Earth movement 4
... are available in two product models - the ... models is that the 6000AT+ includes a membrane ... aerosol for improved detection limits and reduced oxides. ... range of elements by 10-40 times. Note that ...
Request Info...
Request Info...
... catalyzes the formation of a phosphodiester bonds ... nicked duplex DNA molecules or between oligonucleotides ... strand at 45 - 65?. Tfi DNA ... higher temperatures than conventional DNA ligases, Thus, ...
Biology Products: